Position in ALT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,304,072
+$547,848 QoQ
Shares Held
757,919
+32.9% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 210 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Derivatives in ALT
reported options exposure · as of Mar 31, 2023CallValue
$1,477,000
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ALT ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ALT
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,304,072 | 757,919 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,756,224 | 570,203 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,385,455 | 383,783 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,208,055 | 320,440 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,770,992 | 716,019 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,402,760 | 280,552 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,311,418 | 181,889 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $917,971 | 149,507 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,857,596 | 279,338 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,088,695 | 499,872 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $303,490 | 26,977 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $157,295 | 60,499 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $288,303 | 81,673 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,726,735 | 646,146 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $1,477,000 | 350,000 | Call | Defined | 2023-05-12 | |
| 2022-12-31 | $1,645,000 | 100,000 | Call | Defined | 2023-02-10 | |
| 2022-12-31 | $8,712,511 | 529,636 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,277,000 | 100,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $3,348,344 | 262,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $760,183 | 64,973 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $139,083 | 22,838 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,066,221 | 225,570 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,131 | 100 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $242,281 | 21,422 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $181,209 | 18,397 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $324,636 | 22,975 | Shares | Defined | 2021-05-14 | |
| 2020-06-30 | $3,237,622 | 302,299 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||